Walker BD - Search Results

1

Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117.

Caskey M, Klein F, Lorenzi JC, Seaman MS, West AP Jr, Buckley N, Kremer G, Nogueira L, Braunschweig M, Scheid JF, Horwitz JA, Shimeliovich I, Ben-Avraham S, Witmer-Pack M, Platten M, Lehmann C, Burke LA, Hawthorne T, Gorelick RJ, Walker BD, Keler T, Gulick RM, Fätkenheuer G, Schlesinger SJ, Nussenzweig MC. Caskey M, et al. Among authors: walker bd. Nature. 2015 Jun 25;522(7557):487-91. doi: 10.1038/nature14411. Epub 2015 Apr 8. Nature. 2015. PMID: 25855300 Free PMC article. Clinical Trial.

2

HIV infection is blocked in vitro by recombinant soluble CD4.

Fisher RA, Bertonis JM, Meier W, Johnson VA, Costopoulos DS, Liu T, Tizard R, Walker BD, Hirsch MS, Schooley RT, et al. Fisher RA, et al. Among authors: walker bd. Nature. 1988 Jan 7;331(6151):76-8. doi: 10.1038/331076a0. Nature. 1988. PMID: 2829022

3

A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.

Hussey RE, Richardson NE, Kowalski M, Brown NR, Chang HC, Siliciano RF, Dorfman T, Walker B, Sodroski J, Reinherz EL. Hussey RE, et al. Nature. 1988 Jan 7;331(6151):78-81. doi: 10.1038/331078a0. Nature. 1988. PMID: 2829023

4

Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection.

Harrer T, Harrer E, Kalams SA, Elbeik T, Staprans SI, Feinberg MB, Cao Y, Ho DD, Yilma T, Caliendo AM, Johnson RP, Buchbinder SP, Walker BD. Harrer T, et al. Among authors: walker bd. AIDS Res Hum Retroviruses. 1996 May 1;12(7):585-92. doi: 10.1089/aid.1996.12.585. AIDS Res Hum Retroviruses. 1996. PMID: 8743084

5

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. Collins KL, et al. Among authors: walker bd. Nature. 1998 Jan 22;391(6665):397-401. doi: 10.1038/34929. Nature. 1998. PMID: 9450757

6

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.

Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, Smith K, Lisziewicz J, Lori F, Flexner C, Quinn TC, Chaisson RE, Rosenberg E, Walker B, Gange S, Gallant J, Siliciano RF. Finzi D, et al. Nat Med. 1999 May;5(5):512-7. doi: 10.1038/8394. Nat Med. 1999. PMID: 10229227

7

Immune control of HIV-1 after early treatment of acute infection.

Rosenberg ES, Altfeld M, Poon SH, Phillips MN, Wilkes BM, Eldridge RL, Robbins GK, D'Aquila RT, Goulder PJ, Walker BD. Rosenberg ES, et al. Among authors: walker bd. Nature. 2000 Sep 28;407(6803):523-6. doi: 10.1038/35035103. Nature. 2000. PMID: 11029005 Clinical Trial.

8

Immune control of HIV: the obstacles of HLA and viral diversity.

Walker BD, Korber BT. Walker BD, et al. Nat Immunol. 2001 Jun;2(6):473-5. doi: 10.1038/88656. Nat Immunol. 2001. PMID: 11376327 Review. No abstract available.

9

Evolution and transmission of stable CTL escape mutations in HIV infection.

Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, Addo MM, Rosenberg ES, Nguyen T, Allen R, Trocha A, Altfeld M, He S, Bunce M, Funkhouser R, Pelton SI, Burchett SK, McIntosh K, Korber BT, Walker BD. Goulder PJ, et al. Among authors: walker bd. Nature. 2001 Jul 19;412(6844):334-8. doi: 10.1038/35085576. Nature. 2001. PMID: 11460164

10

Less is more? STI in acute and chronic HIV-1 infection.

Altfeld M, Walker BD. Altfeld M, et al. Among authors: walker bd. Nat Med. 2001 Aug;7(8):881-4. doi: 10.1038/90901. Nat Med. 2001. PMID: 11479610 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

674 results

Search Page

Filters